HER2-Positive Metastatic Breast Cancer: What’s New in Treatment and Quality-of-Life

Listen Now

Topics Covered

• HER2-Positive Metastatic Breast Cancer
• Biomarker, Genomic & Diagnostic Testing: Grade & Hormone Receptors
• Standard Treatment Options, Including Targeted Therapy
• How Biomarker Testing Informs Treatment Decisions
• New & Emerging Targeted Treatments
• Updates on Investigational New Drugs in Clinical Trials
• How Research Contributes to Your Treatment Options
• What’s New in the Prevention & Management of Treatment Side Effects, Symptoms, Discomfort, Neuropathy, Pain & Long-Term Effects
• Guidelines to Prepare for Telemedicine/Telehealth Appointments, Including Technology, Prepared List of Questions & Discussion of OpenNotes
• Key Questions to Ask Your Health Care Team About Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

Jennifer M. Matro, MD

Co-Director, Breast Oncology, Fair Oaks Inova Schar Cancer Institute, Inova Health

Saranya Chumsri, MD

Professor of Oncology, Mayo Clinic Breast Disease Group Research Co-Chair, Mayo Clinic HER2 Working Group Co-Chair, Jacoby Center for Breast Health, Mayo Clinic Cancer Center

Cassie Spector, MSW, OSW-C

Breast and Gynecological Cancers Program Coordinator, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 06, 2025.